首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >The Chinese Herbal Medicine Formula Sheng-Fei-Yu-Chuan-Tang Suppresses Th2 Responses and Increases IFNγ in Dermatophagoides pteronyssinus Induced Chronic Asthmatic Mice
【2h】

The Chinese Herbal Medicine Formula Sheng-Fei-Yu-Chuan-Tang Suppresses Th2 Responses and Increases IFNγ in Dermatophagoides pteronyssinus Induced Chronic Asthmatic Mice

机译:中草药方生肺郁汤汤抑制Dermatophagoides pteronyssinus诱发的慢性哮喘小鼠的Th2反应并增加IFNγ

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sheng-Fei-Yu-Chuan-Tang (SFYCT), a traditional Chinese medicine formula consisting of 13 medicinal plants, has been used in the treatment of asthma. This study demonstrated the immunoregulatory effect of SFYCT on chronic allergic asthma using the Dermatophagoides-pteronyssinus- (Der p-) challenged chronic asthmatic murine model. SFYCT decreased the airway hyperresponseness (AHR), pulmonary inflammatory cell infiltration, and airway remodeling in Der p mice. SFYCT treatment decreased Der p-induced total IgE and Der-p-specific IgG1 but not IgG2a/2b Ab titer in serum of Der p mice. SFYCT also decreased Th2 cytokines, IL-4, IL-5, and IL-13, but increased IFN-γ and IL-12 in the BALF of Der p mice. TGF-β1 and collagen production in the lung of mice were decreased by SFYCT. The mRNA expression of chemokine including Eotaxin, RANTES, and MCP-1 in the lung of Der p mice was decreased by SFYCT. In conclusion, the suppressed Der-p-induced airway inflammation, remodeling, and hyperresponseness in chronic asthma murine model are related to SFYCT inhibits Th2 responses, decreases chemokine expression and promotes IFN-γ and IL-12 production. SFYCT could show Der-p-induced Th2 responses to Th1 responses by increasing IFN-γ which is merit for clinical application on asthma patients.
机译:由13种药用植物组成的中药配方盛飞玉川堂(SFYCT)已用于治疗哮喘。这项研究证明了SFYCT对Dermatophagoides-pteronyssinus-(Der p-)攻击的慢性哮喘小鼠模型对慢性过敏性哮喘的免疫调节作用。 SFYCT降低了Der p小鼠的气道高反应性(AHR),肺炎性细胞浸润和气道重塑。 SFYCT处理可降低Der p小鼠血清中Der p诱导的总IgE和Der-p特异性IgG1,但不降低IgG2a / 2b Ab滴度。 SFYCT还降低了Der p小鼠BALF中的Th2细胞因子,IL-4,IL-5和IL-13,但增加了IFN-γ和IL-12。 SFYCT可降低小鼠肺中的TGF-β1和胶原蛋白的产生。 SFYCT降低了Der p小鼠肺中趋化因子包括Eotaxin,RANTES和MCP-1的mRNA表达。总之,慢性哮喘小鼠模型中抑制的Der-p诱导的气道炎症,重塑和高反应性与SFYCT抑制Th2反应,降低趋化因子表达并促进IFN-γ和IL-12产生有关。 SFYCT可以通过增加IFN-γ来显示Der-p诱导的Th2对Th1反应的应答,这对于在哮喘患者中的临床应用是值得的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号